These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9024191)
1. Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus. Löscher W; Hönack D Epilepsia; 1997 Jan; 38(1):106-13. PubMed ID: 9024191 [TBL] [Abstract][Full Text] [Related]
2. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation. Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909 [TBL] [Abstract][Full Text] [Related]
3. Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Hönack D; Löscher W Epilepsy Res; 1992 Dec; 13(3):215-21. PubMed ID: 1493784 [TBL] [Abstract][Full Text] [Related]
4. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802 [TBL] [Abstract][Full Text] [Related]
5. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice. Wlaź P; Roliński Z; Czuczwar SJ Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892 [TBL] [Abstract][Full Text] [Related]
6. Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus. Patel V; Cordato DJ; Malkan A; Beran RG Epilepsy Behav; 2014 Feb; 31():31-3. PubMed ID: 24333499 [TBL] [Abstract][Full Text] [Related]
7. Intravenous carbamazepine for the treatment of epilepsy. Brigo F; Leo A; Russo E; Striano P; Belcastro V Expert Opin Pharmacother; 2018 May; 19(7):743-747. PubMed ID: 29648925 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. McCormack B; Gregoriadis G Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541 [TBL] [Abstract][Full Text] [Related]
10. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Appleton R; Martland T; Phillips B Cochrane Database Syst Rev; 2002; (4):CD001905. PubMed ID: 12519562 [TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. Grabenstatter HL; Clark S; Dudek FE Epilepsia; 2007 Dec; 48(12):2287-95. PubMed ID: 17711461 [TBL] [Abstract][Full Text] [Related]
12. A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models. Ali A; Dua Y; Constance JE; Franklin MR; Dudek FE Epilepsia; 2012 Jan; 53(1):199-206. PubMed ID: 22092257 [TBL] [Abstract][Full Text] [Related]
13. NMDA- but not kainate-mediated events reduce efficacy of some antiepileptic drugs against generalized tonic-clonic seizures in mice. Urbanska EM; Tomczyk T; Haberek G; Pilip S; Matyska J; Turski WA; Kleinrok Z; Czuczwar SJ Epilepsia; 1999 Nov; 40(11):1507-11. PubMed ID: 10565576 [TBL] [Abstract][Full Text] [Related]
14. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles. Löscher W; Nolting B; Fassbender CP Epilepsy Res; 1990 Dec; 7(3):173-81. PubMed ID: 2289477 [TBL] [Abstract][Full Text] [Related]
15. Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins. Brewster ME; Anderson WR; Estes KS; Bodor N J Pharm Sci; 1991 Apr; 80(4):380-3. PubMed ID: 1865340 [TBL] [Abstract][Full Text] [Related]
16. A new injectable carbamazepine solution--antiepileptic effects and pharmaceutical properties. Taubøll E; Lindström S; Klem W; Gjerstad L Epilepsy Res; 1990; 7(1):59-64. PubMed ID: 2292247 [TBL] [Abstract][Full Text] [Related]
17. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use. Holvoet C; Heyden YV; Plaizier-Vercammen J Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403 [TBL] [Abstract][Full Text] [Related]
18. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD. Ma DQ; Rajewski RA; Stella VJ Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430 [TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]